SHIJIAZHUANG NO.4 PHARMACEUTICAL CO.,LTD.

Basic Info.Model NO.Ciprofloxacin Infusion BP 200mg/100mlPharmaceutical TechnologyChemical SynthesisSpecification100mLProduction Capacity1 Billion / YearProduct DescriptionProduct Description

 

Ciprofloxacin 2 mg/ml solution for infusion

Specifaction: Solution for infusion, 100ml PP bottle

Description: Clear, colourless or slightly yellow solution.

Ingredient: Ciprofloxacin 2mg/ml; Sodium Chloride 9mg/ml

INDICATIONS: Ciprofloxacin is a fluoroquinolone antibacterial indicated in adults (≥18 years of age) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated.
1.1 Skin and Skin structure Infections
1.2 Bone and Joint infections
1.3 Complicated Intra-Abdominal infections
1.4 Nosocomial Pneumonia
1.5 Empirical Therapy for Febrile Neutropenic Patients
1.6 Inhalational Anthrax Post-Exposure in Adult and Pediatric Patients
1.7 Plague in adult and pediatric patients
1.8 Chronic Bacterial Prostatitis
1.9 Lower respiratory tract infections
1.10 Acute Exacerbation of Chronic Bronchitis
1.11 Urinary Tract Infections
1.12 Urinary Tract Infections
1.13 Complicated UTI and Pyelonephritis in Pediatric Patients
1.14 Acute Sinusitis

USAGE: To reduce the development of drug-resistant bacteria and maintain the effectiveness of ciprofloxacin and other antibacterial drugs, ciprofloxacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

Manufacturer: Shijiazhuang No.4 Pharmaceutical Co.,Ltd.
Scale: there are 8 workshops, including 5 large volume infusion workshops, two oral preparation workshops and an ampoule workshop. There are 10 dosage forms: large volume injection, irrigation, tablet, capsule, granules, suspension, oral liquid, mixture, and small volume injection, with 156 different products.
Specialty: Our leading product is large volume injection, including PP Bottles, Nom-PVC co-extrusion multiplayer infusion bags, Glass bottles,pack size are 2000ml,1000ml,500ml,250ml,100ml,50ml,the current output is more than 1.2 billion bottles or bags annually.
QRM Principle: to promote quality improvement, to reduce drug risk, to ensure patient safety. By means of risk management of pharmaceutical manufacturing process, the product quality risk can be minimized to ensure the quality of products.

Detailed Photos

 

Certifications